Archimed acquires PET radiopharmaceuticals company IRAB
Tuesday, June 9, 2026 · first reported by PE Hub
Archimed acquires IRAB, a Barcelona-based PET radiopharmaceuticals developer founded in 2016.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Arlington to sell medical device firm Riverpoint Medical for $1.2bnPE Hub
- CapMan Growth exits eye health company Silmäasema for €574mPE Hub
- Thoma Bravo to take validation software firm Kneat private for $466mPE Hub
- Bain Capital joins competitive bidding process for Australia’s oOh!mediaPrivate Equity Wire
- Clearlake snaps up private markets firm Pathway CapitalPE Hub
- Gemspring backs motorcycle parts retailer ComotoPE Hub